A study on management of subjects with Depression with Siddha drugs Venpoosani Nei and Seeraga Thylam

Clinical study of Siddha drugs Venpoosani Nei internally and Seeraga Thylam externally in the treatment of Viyakoola Unmaatham (Depression)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/12/016780

Enrollment

Registered

2018-12-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F430- Acute stress reaction

Interventions

Intervention1: Venpoosani Nei (Internal) and Seeraga Thylam (External): 16 ml of Venpoosani Nei will be administered orally twice a day and 50 ml of Seeraga thylam will be issued for taking oil bath f

Eligibility

Inclusion criteria

Inclusion criteria: 1. Depressed mood 2. Reduced level of interest and enjoyment 3. Reduced level of self esteem and self confidence 4. Reduced energy leading to fatiguability and diminished activity 5. Thoughts of extreme guilt 6. Diminished ability to think and concentrate 7. Bleak and pessimistic views of the future 8. Insomnia or hypersomnia 9. Diminished apetite 10. Considerable weight loss or weight gain

Exclusion criteria

Exclusion criteria: 1. Hypertension and cardiac diseases 2. Malignancy 3. Alcoholic and other drug abuse 4. Patients with any other serious illness 5. Patients with sucidal tendency 6. Patients taking Anti depressant drugs 7. Pregnancy and lactation

Design outcomes

Primary

Measure	Time frame
Reduction in the symptoms of Depression assessed by BECK scaleTimepoint: 48 Days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr Prabakar K

National Institute of Siddha

rvmahalakshmi85@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026